Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028576
Filing Date
2012-05-14
Accepted
2012-05-14 15:46:54
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312837_10q.htm 10-Q 344567
2 EXHIBIT 31.1 v312837_ex31-1.htm EX-31.1 9001
3 EXHIBIT 31.2 v312837_ex31-2.htm EX-31.2 9339
4 EXHIBIT 32.1 v312837_ex32-1.htm EX-32.1 4743
5 EXHIBIT 32.2 v312837_ex32-2.htm EX-32.2 4704
  Complete submission text file 0001144204-12-028576.txt   1757625

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ilns-20120331.xml EX-101.INS 167496
7 XBRL TAXONOMY EXTENSION SCHEMA ilns-20120331.xsd EX-101.SCH 17322
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ilns-20120331_cal.xml EX-101.CAL 30901
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ilns-20120331_def.xml EX-101.DEF 63287
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ilns-20120331_lab.xml EX-101.LAB 146777
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ilns-20120331_pre.xml EX-101.PRE 84133
Mailing Address 45 WEST 36TH STREET 3RD FLOOR NEW YORK NY 10018
Business Address 45 WEST 36TH STREET 3RD FLOOR NEW YORK NY 10018 201 608-5102
Intellect Neurosciences, Inc. (Filer) CIK: 0001337905 (see all company filings)

EIN.: 208329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-128226 | Film No.: 12838526
SIC: 2834 Pharmaceutical Preparations